Come up with a name for your new list and we'll add to it:
Essential Biotechnology raised a round of funding on December 24, 2015. Investors include
Bridge to Cures.
Essential Biotechnology has a new approach to cancer therapy. Existing targeted therapies typically slow the growth of tumors by inhibition of a particular signaling pathway in tumor cells. With chemo…